Mustang Bio Announces $9.28 Million Grant to Fund Phase 1 Trial of CAR T Therapy MB-103 in HER2-Positive Breast Cancer with Brain Metastases

NEXT STORY
Vaccinex Announces Full Enrollment Achieved in Ongoing CLASSICAL-Lung Phase 1b/2 Trial of Pepinemab in Combination with BAVENCIO® (avelumab) in Advanced Non-Small Cell Lung Cancer
PREV STORY
Dehydration Monitoring Systems Market to grow at 9.6% CAGR during (2019-2025) Insights on Key Trends, Technological Development, Growth Drivers, Top Players, and Business Opportunities: Adroit Market Research
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Optimi Health Supports Patient-Focused Psilocybin Advocacy by TheraPsil

author_avatar
NASDAQ Market News

Aclaris Therapeutics’ A-101 45% Topical Solution Meets Primary and All Secondary Efficacy Endpoints in Second Successful Pivotal Phase 3 Clinical Trial for the Treatment of Common Warts (THWART-1)

author_avatar
NASDAQ Market News

Synairgen announces data from Home Cohort of SG016 Phase II trial of inhaled interferon beta in COVID-19 patients and encouraging combined data for whole SG016 trial

author_avatar
NASDAQ Market News